Showing results (111-120 of 352) with videos related to
Sort By:
Pageof 36
Clinical Therapeutics|October 7, 2022
Characteristics of Real-world Commercially Insured Patients With Treatment-resistant Depression Initiated on Esketamine Nasal Spray or Conventional Therapies in the United StatesSwapna Karkare, Maryia Zhdanava, Dominic Pilon, et al.Journal of Managed Care & Specialty Pharmacy|April 26, 2014
Adherence patterns for abiraterone acetate and concomitant prednisone use in patients with prostate cancerMarie-Hélène Lafeuille, Amanda Melina Grittner, Patrick Lefebvre, et al.Crohn'S & Colitis 360|February 13, 2023
Indicators of Suboptimal Treatment and Associated Healthcare Costs Among Patients With Crohn's Disease Initiated on Biologic or Conventional AgentsDominic Pilon, Zhijie Ding, Erik Muser, et al.American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|February 20, 2015
Comparison of rehospitalization rates and associated costs among patients with schizophrenia receiving paliperidone palmitate or oral antipsychoticsMarie-Hélène Lafeuille, Amanda Melina Grittner, Jonathan Fortier, et al.Journal of Health Economics and Outcomes Research|September 13, 2024
Real-World Clinical Outcomes and Treatment Patterns Among Black and Non-Black Patients With Prostate Cancer Initiated on Apalutamide in a Urology SettingBenjamin H Lowentritt, Carmine Rossi, Erik Muser, et al.Current Medical Research and Opinion|January 28, 2021
Risk of subsequent relapses and corresponding healthcare costs among recently-relapsed Medicaid patients with schizophrenia: a real-world retrospective cohort studyCharmi Patel, Bruno Emond, Laura Morrison, et al.Biologics : Targets & Therapy|January 14, 2021
Switching and Discontinuation Patterns Among Patients Stable on Originator Infliximab Who Switched to an Infliximab Biosimilar or Remained on Originator InfliximabTimothy Fitzgerald, Richard Melsheimer, Marie-Hélène Lafeuille, et al.Current Medical Research and Opinion|May 18, 2021
Real-world treatment sequencing and healthcare costs among CLL/SLL patients treated with venetoclaxKerry A Rogers, Bruno Emond, Ameur M Manceur, et al.Current Medical Research and Opinion|April 4, 2017
Importance of balancing follow-up time and impact of oral-anticoagulant users' selection when evaluating medication adherence in atrial fibrillation patients treated with rivaroxaban and apixabanCraig Coleman, Zhong Yuan, Jeff Schein, et al.Drugs - Real World Outcomes|January 25, 2018
Economic Impact in Medicaid Beneficiaries with Schizophrenia and Cardiometabolic Comorbidities Treated with Once-Monthly Paliperidone Palmitate vs. Oral Atypical AntipsychoticsMarie-Hélène Lafeuille, Neeta Tandon, Sean Tiggelaar, et al.Pageof 36